Modification of Α2,6-Sialylation Mediates the Invasiveness and Tumorigenicity of Non-Small Cell Lung Cancer Cells in Vitro and in Vivo via Notch1/Hes1/MMPs Pathway

International Journal of Cancer - United States
doi 10.1002/ijc.31737
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Ganoderan (GDN) Regulates the Growth, Motility and Apoptosis of Non-Small Cell Lung Cancer Cells Through ERK Signaling Pathway in Vitro and in Vivo

OncoTargets and Therapy
OncologyPharmacology
2019English

The Biological-Behavioral Effect of Neuritin on Non-Small Cell Lung Cancer Vascular Endothelial Cells via VEGFR and Notch1

OncoTargets and Therapy
OncologyPharmacology
2019English

In Vitro and in Vivo Effects of the Conformationally Restricted Polyamine Analogue CGC-11047 on Small Cell and Non-Small Cell Lung Cancer Cells

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2008English

miR-154 Suppresses Non-Small Cell Lung Cancer Growth in Vitro and in Vivo

Oncology Reports
MedicineCancer ResearchOncology
2015English

WT1-interacting Protein Inhibits Cell Proliferation and Tumorigenicity in Non-Small Cell Lung Cancer via the AKT/FOXO1 Axis

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

CCL21/CCR7 Prevents Apoptosis via the ERK Pathway in Human Non-Small Cell Lung Cancer Cells

PLoS ONE
Multidisciplinary
2012English

FAM98A Promotes Proliferation of Non-Small Cell Lung Cancer Cells via the P38-Atf2 Signaling Pathway

Cancer Management and Research
Oncology
2018English

A Novel Small Inhibitor, LLL12, Targets STAT3 in Non‑small Cell Lung Cancer In�vitro and In�vivo

Oncology Letters
Cancer ResearchOncology
2018English

P026 Control of Α2,6-Sialylation in B-Cells, and Consequences of Reduced B-Cell Sialylation in Patients With Rheumatoid Arthritis

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy